Since PCK2-mediated metabolism is critical for the survival of NSCLC cells, targeting ER stress-ATF4 signaling pathway could be a therapeutic approach for the treatment of NSCLC. The gene discussed is PCK2; the disease is non-small cell lung carcinoma.